ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Actavis Infringes Orexo's Long Term Zubsolv U.S. Patent ′330 americanpharmaceuticalreview
January 14, 2019Orexo announces that the United States District Court for the District of Delaware has issued a final, non-appealable judgement that Actavis's generic Zubsolv products infringe Orexo's U.S. patent No. 8,940,330.....
Pharma Sources Insight January 2025
